ANAVEX LIFE SCIENCES CORP. (AVXL) Executive Compensation
ANAVEX LIFE SCIENCES CORP. (AVXL) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AVXL
CIK: 1314052
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 09/30
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Grant Thornton LLP
Auditor SinceSince 9/30/2022 12:00:00 AM
Lead Engagement PartnerStephen Dagnell
Audit LocationMelville, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 8-K | 2026-10-15 | 2026-10-15 | FORM 8-K | 0001731122-26-001348 | View SEC Doc Filr Page |
| 3 | 2026-10-05 | 2026-09-24 | 3 Filing | 0001731122-26-001317 | View SEC Doc Filr Page |
| 3 | 2026-10-05 | 2026-09-24 | 3 Filing | 0001731122-26-001314 | View SEC Doc Filr Page |
| 4 | 2026-09-28 | 2026-09-24 | 4 Filing | 0001731122-26-001296 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-24 | FORM 8-K | 0001731122-26-001294 | View SEC Doc Filr Page |
| DFAN14A | 2026-09-21 | — | DFAN14A | 0001493152-26-043435 | View SEC Doc Filr Page |
| DFAN14A | 2026-09-18 | — | DFAN14A | 0001493152-26-043345 | View SEC Doc Filr Page |
| DFAN14A | 2026-09-17 | — | DFAN14A | 0001493152-26-043079 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-15 | — | FORM DEFA14A | 0001731122-26-001244 | View SEC Doc Filr Page |
| DFAN14A | 2026-09-15 | — | DFAN14A | 0001493152-26-042718 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-14 | — | FORM DEFA14A | 0001731122-26-001235 | View SEC Doc Filr Page |
| DFAN14A | 2026-09-10 | — | DFAN14A | 0001493152-26-042192 | View SEC Doc Filr Page |
| DFAN14A | 2026-09-10 | — | DFAN14A | 0001493152-26-042019 | View SEC Doc Filr Page |
| DFAN14A | 2026-09-09 | — | DFAN14A | 0001493152-26-041997 | View SEC Doc Filr Page |
| 8-K | 2026-09-09 | 2026-09-09 | FORM 8-K | 0001731122-26-001211 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-08 | — | FORM DEFA14A | 0001731122-26-001207 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-04 | — | FORM DEFA14A | 0001731122-26-001194 | View SEC Doc Filr Page |
| DFAN14A | 2026-09-04 | — | DFAN14A | 0001493152-26-041425 | View SEC Doc Filr Page |
| DFAN14A | 2026-09-03 | — | DFAN14A | 0001493152-26-041287 | View SEC Doc Filr Page |
| 8-K | 2026-09-02 | 2026-09-02 | FORM 8-K | 0001731122-26-001179 | View SEC Doc Filr Page |
| DFAN14A | 2026-09-02 | — | DFAN14A | 0001493152-26-041140 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-01 | — | FORM DEFA14A | 0001731122-26-001175 | View SEC Doc Filr Page |
| DEFA14A | 2026-08-31 | — | FORM DEFA14A | 0001731122-26-001171 | View SEC Doc Filr Page |
| 10-Q | 2026-08-28 | 2026-06-30 | FORM 10-Q | 0001731122-26-001167 | View SEC Doc Filr Page |
| 10-Q | 2026-08-28 | 2026-03-31 | FORM 10-Q | 0001731122-26-001166 | View SEC Doc Filr Page |